vimarsana.com

கார்னகி இந்தியா உலகளாவிய தொழில்நுட்பம் உச்சிமாநாடு ஆன் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

COVID-19 vaccine manufacturers must be protected from lawsuits: SII CEO Adar Poonawalla

COVID-19 vaccine manufacturers must be protected from lawsuits: SII CEO Adar Poonawalla Poonawalla made these comments at an online panel on the challenges of developing a COVID-19 vaccine at the Carnegie India s Global Technology Summit Share Updated: Dec 20, 2020, 07:26 AM IST The Chief Executive Officer of Serum Institute of India (SII) Adar Poonawalla has expressed his displeasure over lawsuits and claims filed against vaccine makers. He urged the government to protect vaccine makers against lawsuits during the COVID-19 pandemic. Poonawalla made these comments at an online panel on the challenges of developing a COVID-19 vaccine at the Carnegie India s Global Technology Summit on Friday.

Adar Poonawalla government must indemnify vaccine makers against all lawsuits

URL copied Govt must indemnify vaccine makers against all lawsuits: Adar Poonawalla Vaccine manufacturers need to have protection against all lawsuits for their vaccines especially during a pandemic, Serum Institute of India (SII) Chief Executive Officer Adar Poonawalla has said. He also said that the vaccine makers are going to propose this to the government while speaking at a virtual panel on the challenges of developing a COVID-19 vaccine at the Carnegie India s Global Technology Summit on Friday. We need to have the government indemnify manufacturers, especially vaccine manufacturers, against all lawsuits. In fact, COVAX and other countries have already started talking about that, Poonawalla said.

Govt needs to protect vaccine manufacturers against all lawsuits, says SII CEO Adar Poonawalla

Govt needs to protect vaccine manufacturers against all lawsuits, says SII CEO Adar Poonawalla Last month, SII had rejected allegations of serious side-effects made by a participant in the Covishield vaccine trial in Chennai. The man had also sought Rs 5 crore compensation Adar Poonawalla. Twitter@adarpoonawalla New Delhi: Vaccine manufacturers need to have protection against all lawsuits for their vaccines especially during a pandemic, Serum Institute of India (SII) chief executive officer Adar Poonawalla has said. He also said that the vaccine makers are going to propose this to the government while speaking at a virtual panel on the challenges of developing a COVID-19

Poonawalla bats for vaccine makers, demands indemnifier against lawsuits

Poonawalla bats for vaccine makers, demands indemnifier against lawsuits It is because when frivolous claims come up, scepticism sets in Vaccine manufacturers need to have protection against all lawsuits for their vaccines especially during a pandemic, Serum Institute of India (SII) Chief Executive Officer Adar Poonawalla has said. He also said that the vaccine makers are going to propose this to the government, while speaking at a virtual panel on the challenges of developing a Covid-19 vaccine at the Carnegie India s Global Technology Summit on Friday. We need to have the government indemnify manufacturers, especially vaccine manufacturers, against all lawsuits. In fact, COVAX and other countries have already started talking about that, Poonawalla said.

COVID-19 vaccine makers must be protected from lawsuits, claims during pandemic: SII s Adar Poonawalla

Highlights Serum Institute of India s Adar Poonawalla has urged the government to protect vaccine manufacturers against lawsuits and claims. Poonawalla said that claims invite skepticism and that hampers the chances of rolling out the said vaccine. The government needs to step in to spread the right information, he argued. New Delhi: The Chief Executive Officer of Serum Institute of India (SII) Adar Poonawalla expressed his concerns about lawsuits and claims filed against vaccine makers. He urged the government to protect vaccine manufacturers against all lawsuits especially during a pandemic.  While addressing an online panel on the challenges of developing a

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.